Back to results
US 2021/0071248 A1Published application
Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents
AssigneeThe General Hospital Corporation
InventorsJ. Keith Joung, Vikram Pattanayak, Karl Petri
Life of this patent
Estimating the term…
Abstract
Methods and compositions for performing highly sensitive in vitro assays to define substrate preferences and off-target sites of nucleic-acid binding, modifying, and cleaving agents.
Claims13
A method of identifying double stranded DNA sequences that are cleaved, modified, or bound by an enzyme, the method comprising:
- (i) providing a plurality of linear dsDNA oligonucleotides of known sequences, each oligonucleotide having a first strand comprising, from 5′ to 3′:
- a first common sequence common to each of the oligonucleotides in the plurality;
- a first barcode sequence;
- a potential DNA substrate sequence for the cytidine deaminase base editing enzyme comprising a cognate protospacer adjacent motif (PAM);
- a second barcode sequence;
- and
- a second common sequence common to each each of the oligonucleotides,
- wherein the first barcode sequence and the second barcode sequence are uniquely associated with the potential DNA substrate sequence;
- and
- a second strand complementary to the first strand;
- (ii) incubating the plurality in the presence of an enzyme selected from site-specific nucleases, DNA modifying proteins, and DNA binding domains, under conditions sufficient for cleavage, modification, or binding of one or more of the linear dsDNA oligonucleotides to occur;
- (iii) selecting, and optionally enriching for, oligonucleotide(s) that are cleaved, modified, or bound;
- and
- (iv) determining the sequence(s) of the selected oligonucleotide(s) that are cleaved, modified, or bound, thereby identifying double stranded DNA sequences that are cleaved, modified, or bound by an enzyme.
11 more elements
A method of identifying double stranded DNA sequences that are cleaved, modified, or bound by an enzyme, the method comprising:
- (i) providing an initial plurality of linear dsDNA oligonucleotides of known sequences, each oligonucleotide having a first strand comprising, from 5′ to 3′:
- a first common sequence common to each of the oligonucleotides in the plurality;
- a first barcode sequence;
- a potential DNA substrate sequence for the cytidine deaminase base editing enzyme comprising a cognate protospacer adjacent motif (PAM);
- a second barcode sequence;
- and
- a second common sequence common to each each of the oligonucleotides,
- wherein the first barcode sequence and the second barcode sequence are uniquely associated with the potential DNA substrate sequence;
- and
- a second strand complementary to the first strand;
- (ii) incubating the plurality in the presence of an enzyme selected from site-specific nucleases, modifying proteins, and DNA binding domains, under conditions sufficient for cleavage, modification, or binding of one or more of the linear dsDNA oligonucleotides to occur;
- (iii) selecting oligonucleotide(s) that are not cleaved, modified, or bound;
- and
- (iv) determining the sequence(s) of the selected oligonucleotide(s) that are not cleaved, modified, or bound;
- and
- (v) comparing the sequence(s) of the selected oligonucleotide(s) that are not cleaved, modified, or bound to one or more of the of the initial plurality of pre-enriched linear dsDNA oligonucleotides of known sequences;
- wherein the linear dsDNA oligonucleotide(s) in the initial plurality that were not selected are identified as being cleaved, modified, or bound by the enzyme.
14 more elements
-7. (canceled)
(canceled)
-15. (canceled)
Dependencies are inferred from the claim text.